Paper3000620
Chicken myeloid stem cells infected by retroviruses carrying the v-fps oncogene do not require exogenous growth factors to differentiate in vitro.
Carmier JF and 1 other. Cell, 1986. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Chicken myeloid stem cells infected by retroviruses carrying the v-fps oncogene do not require exogenous growth factors to differentiate in vitro. Papers, record 3000620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chicken myeloid stem cells infected by retroviruses carrying the v-fps oncogene do not require exogenous growth factors to differentiate in vitro.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Avian Sarcoma Viruses | Major topic |
| Cell Differentiation | Major topic |
| Genes, Viral | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Oncogenes | Major topic |
| Viral Proteins | Major topic |
| Animals | |
| Bone Marrow Cells | |
| Cells, Cultured | |
| Chickens | |
| Colony-Stimulating Factors | |
| Defective Viruses | |
| Macrophages |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17183165 | Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes. | Acta Crystallogr Sect F Struct Biol Cryst Commun | 2007 | https://conductscience.org/library/papers/17183165 | PubMed |
| 11865067 | Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11865067 | PubMed |
| 10523632 | Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10523632 | PubMed |
| 7682176 | c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. | EMBO J | 1993 | https://conductscience.org/library/papers/7682176 | PubMed |
| 7529874 | Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7529874 | PubMed |
| 3077064 | Control of myogenic differentiation by cellular oncogenes. | Mol Neurobiol | 1988 | https://conductscience.org/library/papers/3077064 | PubMed |
| 3034604 | Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine. | EMBO J | 1987 | https://conductscience.org/library/papers/3034604 | PubMed |
| 2440024 | Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2440024 | PubMed |
| 2164029 | The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. | J Cell Biol | 1990 | https://conductscience.org/library/papers/2164029 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3000620
GET https://conductscience.org/api/papers/v1/3000620/authors